Irene Vanni

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma.

Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma.

Journal: International journal of molecular sciences

Published: July 02, 2025

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab.

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab.

Journal: Journal of translational medicine

Published: June 11, 2025

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.

Journal: Clinical and experimental medicine

Published: April 12, 2024

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.

Journal: Journal of translational medicine

Published: February 23, 2024

Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome.

Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome.

Journal: Genes

Published: December 18, 2023

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.

Journal: International journal of molecular sciences

Published: December 20, 2022

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.

Journal: International journal of molecular sciences

Published: November 11, 2022

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

Journal: Cancers

Published: August 08, 2022

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.

Journal: ESMO open

Published: April 15, 2022

Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments.

Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments.

Journal: Journal of personalized medicine

Published: December 29, 2020

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: December 28, 2020

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).

Journal: Diagnostic pathology

Published: July 17, 2020

Showing 1-12 of 53

Last Updated: 09/26/2026